炎症性肠病中病毒性肝炎的预防与管理：韩国肠道疾病研究协会临床实践指南
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases.
作者信息
Park Soo-Kyung, Choi Chang Hwan, Chun Jaeyoung, Lee Heeyoung, Kim Eun Sun, Park Jae Jun, Park Chan Hyuk, Lee Bo-In, Jung Yunho, Park Dong-Il, Kim Do Young, Park Hana, Jeen Yoon Tae
机构信息
Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
出版信息
Intest Res. 2020 Jan;18(1):18-33. doi: 10.5217/ir.2019.09155. Epub 2020 Jan 30.
Abstract
The treatment of inflammatory bowel disease (IBD) has been revolutionized for the last 10 years by the increasing use of immunomodulators and biologics. With immunosuppression of this kind, opportunistic infection is an important safety concern for patients with IBD. In particular, viral hepatitis is determined by the interaction between the virus and the host's immunity, and the risk of reactivation increases if immunity is compromised by immunosuppression therapy. Parts of Asia, including Korea, still show intermediate endemicity for the hepatitis A virus and hepatitis B virus compared with the United States and Western Europe. Thus, members of IBD research group of the Korean Association for the Study of Intestinal Diseases have produced a guideline on the prevention and management of viral hepatitis in IBD.
摘要
在过去十年中，免疫调节剂和生物制剂的使用日益增加，彻底改变了炎症性肠病（IBD）的治疗方式。对于接受此类免疫抑制治疗的IBD患者而言，机会性感染是一个重要的安全问题。特别是，病毒性肝炎取决于病毒与宿主免疫力之间的相互作用，并且如果免疫抑制疗法损害了免疫力，病毒再激活的风险就会增加。与美国和西欧相比，包括韩国在内的部分亚洲地区，甲型肝炎病毒和乙型肝炎病毒的流行程度仍处于中等水平。因此，韩国肠道疾病研究协会IBD研究小组的成员制定了一份关于IBD患者病毒性肝炎预防和管理的指南。
相似文献
1
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases.炎症性肠病中病毒性肝炎的预防与管理：韩国肠道疾病研究协会临床实践指南
Intest Res. 2020 Jan;18(1):18-33. doi: 10.5217/ir.2019.09155. Epub 2020 Jan 30.
2
[Viral Hepatitis in Patients with Inflammatory Bowel Disease].[炎症性肠病患者的病毒性肝炎]
Korean J Gastroenterol. 2022 Aug 25;80(2):51-59. doi: 10.4166/kjg.2022.096.
3
Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.综述文章：炎症性肠病患者乙型肝炎和丙型肝炎感染的预防和管理。
Aliment Pharmacol Ther. 2011 Mar;33(6):619-33. doi: 10.1111/j.1365-2036.2010.04570.x.
4
Viral hepatitis and inflammatory bowel disease.病毒性肝炎和炎症性肠病。
Inflamm Bowel Dis. 2010 Jun;16(6):925-32. doi: 10.1002/ibd.21284.
5
Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future.韩国炎症性肠病队列研究：现状与未来
Intest Res. 2015 Jul;13(3):213-8. doi: 10.5217/ir.2015.13.3.213. Epub 2015 Jun 9.
6
Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.乙型肝炎免疫和英夫利昔单抗治疗的炎症性肠病儿童对加强疫苗接种的反应。
Am J Gastroenterol. 2012 Jan;107(1):133-8. doi: 10.1038/ajg.2011.295. Epub 2011 Aug 30.
7
Prevalence of hepatitis-B viral markers in patients with inflammatory bowel disease in a hepatitis-B-endemic area: inadequate protective antibody levels in young patients.乙肝流行地区炎症性肠病患者乙肝病毒标志物的流行情况：年轻患者保护性抗体水平不足
J Clin Gastroenterol. 2014 Jul;48(6):553-8. doi: 10.1097/01.mcg.0000436435.75392.23.
8
Infections and inflammatory bowel disease: challenges in Asia.感染与炎症性肠病：亚洲面临的挑战。
J Dig Dis. 2013 Nov;14(11):567-73. doi: 10.1111/1751-2980.12091.
9
Serious and Opportunistic Infections in Elderly Patients With Inflammatory Bowel Disease.老年炎症性肠病患者的严重及机会性感染
Gastroenterol Hepatol (N Y). 2019 Nov;15(11):593-605.
10
Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.免疫抑制治疗对炎症性肠病患者乙肝疫苗接种的影响
Eur J Gastroenterol Hepatol. 2015 Aug;27(8):877-81. doi: 10.1097/MEG.0000000000000370.
引用本文的文献
1
The impact of medication belief on adherence to infliximab in patients with Crohn's disease.药物信念对克罗恩病患者英夫利昔单抗治疗依从性的影响。
Front Pharmacol. 2023 Aug 14;14:1185026. doi: 10.3389/fphar.2023.1185026. eCollection 2023.
2
Iranian Consensus Guideline for Pharmacotherapy with Biologics and Small Molecules Drugs in Adults with Inflammatory Bowel Diseases.伊朗成人炎症性肠病生物制剂和小分子药物药物治疗共识指南。
Middle East J Dig Dis. 2023 Apr;15(2):83-106. doi: 10.34172/mejdd.2023.327. Epub 2023 Apr 30.
3
Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review.黄酮类化合物槲皮素和水飞蓟素在病毒相关性炎症性肠病中的保护作用：最新综述。
Arch Microbiol. 2023 May 30;205(6):252. doi: 10.1007/s00203-023-03590-0.
4
Do We Have an Opportunity to Avoid Opportunistic Infections in Asian Patients with Inflammatory Bowel Disease?我们是否有机会避免亚洲炎症性肠病患者发生机会性感染？
Gut Liver. 2022 Sep 15;16(5):663-664. doi: 10.5009/gnl220364.
5
Vaccination strategies for Korean patients with inflammatory bowel disease.韩国炎症性肠病患者的疫苗接种策略。
Korean J Intern Med. 2022 Sep;37(5):920-930. doi: 10.3904/kjim.2022.149. Epub 2022 Aug 8.
6
Inflammatory bowel disease in Korea: epidemiology and pathophysiology.韩国的炎症性肠病：流行病学和病理生理学。
Korean J Intern Med. 2022 Sep;37(5):885-894. doi: 10.3904/kjim.2022.138. Epub 2022 Jul 29.
7
Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease.接受抗肿瘤坏死因子α制剂治疗的炎症性肠病患者的乙型肝炎病毒抗病毒预防
Gut Liver. 2022 Jul 15;16(4):501-502. doi: 10.5009/gnl220186.
8
Current Status of Opportunistic Infection in Inflammatory Bowel Disease Patients in Asia: A Questionnaire-Based Multicenter Study.亚洲炎症性肠病患者机会性感染的现状：一项基于问卷的多中心研究。
Gut Liver. 2022 Sep 15;16(5):726-735. doi: 10.5009/gnl210217. Epub 2022 May 25.
9
SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID.针对成年炎症性肠病患者的新型冠状病毒2型疫苗接种：韩国炎症性肠病学会专家共识声明
Intest Res. 2022 Apr;20(2):171-183. doi: 10.5217/ir.2021.00098. Epub 2022 Jan 5.
10
Natural history of inflammatory bowel disease: a comparison between the East and the West.炎症性肠病的自然史：东西方比较
Intest Res. 2022 Oct;20(4):418-430. doi: 10.5217/ir.2021.00104. Epub 2021 Dec 2.
本文引用的文献
1
KASL clinical practice guidelines for management of chronic hepatitis B.《慢性乙型肝炎管理的KASL临床实践指南》
Clin Mol Hepatol. 2019 Jun;25(2):93-159. doi: 10.3350/cmh.2019.1002. Epub 2019 Jun 12.
2
Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia.亚洲溃疡性结肠炎和克罗恩病免疫调节剂及生物制剂的最佳实践
Intest Res. 2019 Jul;17(3):285-310. doi: 10.5217/ir.2019.00026. Epub 2019 May 31.
3
Improving the quality of care for inflammatory bowel disease.提高炎症性肠病的护理质量。
Intest Res. 2019 Jan;17(1):45-53. doi: 10.5217/ir.2018.00113. Epub 2018 Nov 20.
4
Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel.更新：免疫实践咨询委员会关于使用甲型肝炎疫苗进行接触后预防和国际旅行接触前预防的建议。
MMWR Morb Mortal Wkly Rep. 2018 Nov 2;67(43):1216-1220. doi: 10.15585/mmwr.mm6743a5.
5
2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C.2017年丙型肝炎管理的KASL临床实践指南：慢性丙型肝炎的治疗
Clin Mol Hepatol. 2018 Sep;24(3):169-229. doi: 10.3350/cmh.2018.1004. Epub 2018 Aug 10.
6
Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease.新诊断炎症性肠病患者对乙型肝炎病毒感染无免疫力。
Intest Res. 2018 Jul;16(3):400-408. doi: 10.5217/ir.2018.16.3.400. Epub 2018 Jul 27.
7
EASL Recommendations on Treatment of Hepatitis C 2018.2018年欧洲肝脏研究学会丙型肝炎治疗推荐意见
J Hepatol. 2018 Aug;69(2):461-511. doi: 10.1016/j.jhep.2018.03.026. Epub 2018 Apr 9.
8
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.慢性乙型肝炎的预防、诊断和治疗最新进展：美国肝病研究学会2018年乙型肝炎指南
Hepatology. 2018 Apr;67(4):1560-1599. doi: 10.1002/hep.29800.
9
Prophylactic effect of lamivudine on chemotherapy-induced hepatitis B virus reactivation in patients with solid tumour: A meta-analysis.拉米夫定对实体瘤患者化疗引起的乙型肝炎病毒再激活的预防作用：一项荟萃分析。
Eur J Cancer Care (Engl). 2018 Mar;27(2):e12799. doi: 10.1111/ecc.12799. Epub 2017 Dec 19.
10
Current status and strategies for the control of viral hepatitis A in Korea.韩国甲型病毒性肝炎的防控现状与策略。
Clin Mol Hepatol. 2017 Sep;23(3):196-204. doi: 10.3350/cmh.2017.0034. Epub 2017 Sep 19.
Zotero 插件